Answers are grounded in this paper and cite their sources.
A retrospective (N = 140) and a prospective (N = 102) observational Israeli study by Bar-Sela and colleagues about cannabis potentially adversely impacting the response to immunotherapy have together been cited 202 times, including by clinical practice guidelines. There have also been concerns on PubPeer outlining irregularities and unverifiable information in their statistics and numerous errors in calculating percentages. This reanalysis attempted to verify the data analysis while including non-parametric statistics. The corrected prospective report contained 22
No takes yet. Share an insight, caveat, or question.
Piper et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: